Evaluating apheresis platelets at reduced dose as a contingency measure for extreme shortages.

Smethurst, Peter A; McAndrew, Margaret; Proffitt, Susan; Procter, Simon; Davies, Jane; New, Helen V; Stanworth, Simon J; Doughty, Heidi; Cardigan, Rebecca

Smethurst, Peter A; McAndrew, Margaret; Proffitt, Susan; Procter, Simon; Davies, Jane; New, Helen V; Stanworth, Simon J; Doughty, Heidi; Cardigan, Rebecca.

Afiliação

Smethurst PA; Component Development Laboratory, NHS Blood and Transplant, Cambridge, UK.
McAndrew M; Component Development Laboratory, NHS Blood and Transplant, Cambridge, UK.
Proffitt S; Component Development Laboratory, NHS Blood and Transplant, Cambridge, UK.
Procter S; Quality Monitoring, NHS Blood and Transplant, London, UK.
Davies J; Technical & Scientific Development, NHS Blood and Transplant, London, UK.
New HV; Centre for Haematology, Imperial College London, London, UK.
Stanworth SJ; Clinical Services Directorate, NHS Blood and Transplant, London, UK.
Doughty H; Clinical Services Directorate, NHS Blood and Transplant, London, UK.
Cardigan R; Radcliffe Department of Medicine, University of Oxford, and NIHR Oxford Biomedical Research Centre, Oxford, UK.

Transfusion ; 62(1): 173-182, 2022 01.

Article em En | MEDLINE | ID: mdl-34757639

Assuntos

Plaquetas; COVID-19; Plaquetas/metabolismo; Preservação de Sangue; Humanos; Contagem de Plaquetas; Plaquetoferese

Palavras-chave

dose; platelets; storage lesion

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 4_TD Base de dados: MEDLINE Assunto principal: Plaquetas / COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Transfusion Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google